Maximum Dose of Isosorbide Mononitrate
The maximum recommended dose of isosorbide mononitrate is 240 mg once daily for extended-release formulations, though doses above 20 mg twice daily (40 mg total daily) for immediate-release formulations have not been adequately studied. 1
Dosing by Formulation Type
Immediate-Release Isosorbide Mononitrate
- Standard dosing: 20 mg twice daily, with doses given 7 hours apart 1
- Maximum studied dose: The FDA label explicitly states that "doses above 20 mg twice a day (with the doses seven hours apart) have not been adequately studied" 1
- Starting dose: 5-10 mg, increased to at least 10 mg by day 2-3 1
- Critical timing: The asymmetric dosing schedule (7 hours between doses) provides a nitrate-free interval to prevent tolerance development 1
Extended-Release Isosorbide Mononitrate
- Maximum effective dose: 240 mg once daily 2
- Dose range studied: 30-240 mg once daily in controlled trials 2
- Optimal doses: 120 mg and 240 mg once daily demonstrated sustained efficacy over 6 weeks, maintaining statistical superiority over placebo, while lower doses (30-60 mg) eventually lost statistical significance despite maintaining improvements from baseline 2
Evidence Quality and Dosing Efficacy
The extended-release formulation data comes from a rigorous double-blind study of 313 patients showing that:
- After 42 days, 120 mg and 240 mg doses exceeded placebo by 50-60 seconds in exercise time at 4 hours post-dose (p<0.01) 2
- These higher doses maintained 30-35 seconds improvement at 12 hours (p≤0.05) 2
- Lower doses (30-60 mg) showed initial efficacy but lost statistical significance by week 6 due to placebo group improvement 2
Critical Tolerance Considerations
The dosing schedule matters as much as the total dose to prevent nitrate tolerance:
- Immediate-release: 7-hour interval between doses provides adequate nitrate-free period 1
- Extended-release: Once-daily morning dosing naturally creates a nitrate-free overnight interval 2
- Continuous 24-hour plasma levels result in refractory tolerance 1
Clinical Context from Heart Failure Guidelines
While the 2022 AHA/ACC/HFSA guidelines reference isosorbide dinitrate (not mononitrate) with maximum doses of 120 mg total daily in divided doses for heart failure 3, this is a different medication with different pharmacokinetics and should not be confused with isosorbide mononitrate dosing.
Key Caveats
- No dose adjustment needed for elderly patients or those with hepatic/renal dysfunction 1
- Headache is the most common adverse effect, usually mild-to-moderate and improving with continued therapy 1, 2
- Abrupt discontinuation may exacerbate anginal symptoms after long-term use 4
- No rebound ischemia has been demonstrated at the end of the dosing interval with proper scheduling 2